May 13, 2021
3 min watch
Save
VIDEO: Fluocinolone acetonide implant studied in patients lost to follow-up
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
WAILEA, Hawaii — In this video from Retina 2021, Caesar K. Luo, MD, discusses an analysis investigating patients with diabetic retinopathy and fluocinolone acetonide implant who were lost to follow-up compared with anti-VEGF monotherapy.
The investigation focused on Iluvien (Alimera Sciences).
Published by:
Sources/Disclosures
Collapse
Source:
Caesar K. Luo, MD
Disclosures:
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.